Investing
Cathie Wood's ARK Invest Sells Over 60,000 Shares of Pluristem Therapeutics
Published:
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 62,000 shares of Pluristem Therapeutics Inc. (NASDAQ: PSTI) on Tuesday, as the share price of this fund traded up less than 1% in the day’s session. That share price has greatly improved over the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 62,738 shares of Pluristem. At Tuesday’s closing price, this would have valued this sale at roughly $252,000. This is only a small fraction of the total holdings. This fund is up 84% over the past 52 weeks.
Here is a quick look at all the other sales that took place across all ARK ETFs:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKG | CSTL | Castle Biosciences | 4,800 |
| ARKG | PSTI | Pluristem Therapeutics | 62,738 |
| ARKQ | GLEO | Galileo Acquisition | 1,798 |
| ARKQ | RAVN | Raven Industries | 8,104 |
| ARKW | LC | LendingClub | 82 |
| ARKW | PD | PagerDuty | 6,567 |
| ARKW | ROKU | Roku | 5,986 |
| ARKW | SE | Sea | 21,337 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
24/7 Wall St.Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
